临床药师干预前后门冬氨酸钾镁注射液使用情况比较

Application Comparison of Potassium Magnesium Aspartate before and after the Intervention of Clinical Pharmacists

目的:探讨临床药师干预对门冬氨酸钾镁注射液合理使用的影响。方法:对2013年第四季度和2014年第二季度应用门冬氨酸钾镁注射液的门、急诊处方进行收集与分析,比较干预前后该药使用情况的变化。结果:干预前用药不合理的处方占35.4%,干预后用药不合理的处方占15.8%,差异有统计学意义(P<0.01)。干预后门冬氨酸钾镁注射液在超适应证用药、药液浓度过高、配伍不合理方面与干预前相比差异均有统计学意义(P<0.01或P<0.05)。结论:临床药师对门冬氨酸钾镁注射液的干预是有效的,且仍需持续干预。

To explore the effect of the intervention of clinical pharmacists on the rational use of potassium magnesium aspartate . Methods：The prescriptions of outpatients in the fourth quarter of 2013 and those of emergency in the second quarter of 2014 with potassium magnesium aspartate injection were collected and analyzed. The unreasonable use rate of the drug before and after the intervention was compared. Results：The unreasonable use rate of potassium magnesium aspartate before the intervention was 35. 4%, that after the intervention was 15. 8%, and the difference was statistically significant（P〈0. 01） . The difference in beyond the indica-tion, high concentration and unreasonable compatibility of the drug before and after the intervention was statistically significant （ P〈0. 01 or P〈0. 05） . Conclusion： The intervention of clinical pharmacists in the use of potassium magnesium aspartate is effective, which should be performed continuously.